A new study unveiled a groundbreaking approach to predicting the effectiveness of treatments for patients with Diffuse Large B-Cell Lymphoma (DLBCL), a common form of blood cancer.
A study led by researchers at Brighton and Sussex Medical School (BSMS) has unveiled an approach to predicting the effectiveness of treatments for patients with diffuse large B-cell lymphoma (DLBCL), a common form of blood cancer.
The research received funding from AstraZeneca, Prostate Cancer UK, Cancer Research UK, the Medical Research Council, Movember and the Prostate Cancer Foundation
The research received funding from AstraZeneca, Prostate Cancer UK, Cancer Research UK, the Medical Research Council, Movember and the Prostate Cancer Foundation
(MedPage Today) -- Women with early-stage breast cancer who couldn't enter clinical trials of cryoablation because of "unfavorable" tumor or patient characteristics nevertheless enjoyed a high rate of treatment success and few adverse…
A host of stars have joined Dead Ringers co-creator and prostate cancer patient Jon Holmes to share gory details of their illnesses and get men talking. It's all about finding humour in the darkest of places, explains the broadcaster and…
Addison Hill, a 14-year-old from Fergus, Ont., died from a rare form of cancer in 2022. Her family and friends have held an event in her memory to raise money for sarcoma research.
For years, doctors treating patients have often observed that severe life events - bereavements, divorce and serious trauma - often occur in the years immediately before the onset of the disease.
While the condition, called lymphoedema, affects about 300,000 Britons - the most common cause is cancer treatment - few are able to access the £15,000 procedure on the health service.
Patients battling cancer are urging the Federal Government to provide free treatment, similar to the support available for those with HIV/AIDS. The patients made their appeal at the Ahmadu Bello University Teaching Hospital, Shika.…
Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with roughly 700 new diagnoses every…